Ensuring excellent quality

Pronova BioPharma holds a manufacturing license for medicinal products issued by the Norwegian Medicines Agency for the manufacture of omega-3-fatty acids and derivatives from marine-orginated oil, including control and release of omega-3 capsules. A prerequisite for this licence is in compliance with the European Guide to Good Manufacturing Practice (EU-GMP).

Our Sandefjord facility is also successfully inspected by the USA and South Korean regulatory authorities for supply of active pharmaceutical ingredient (API) to the respective markets.

Pronova BioPharma is committed to quality within the development, manufacturing and testing of the products to meet GMP requirements and regulatory expectations. We work to ensure continuous quality improvements through establishing individual and department objectives that are continuously measured.